Realistic lung model could help improve aerosol drug delivery; 3-D printing offers pill-design potential;

> Researchers at Australia's Curtin University developed a physiologically realistic lung model to simulate airflow and study ways to enhance aerosol drug delivery. Article

> Through three-dimensional printing, researchers in the U.K. are investigating ways to design pills that are more effective and efficient drug-delivery tools. Story

> Flexion Therapeutics posted results for its intra-articular, sustained release steroid to treat osteoarthritis, showing positive data for its duration and delivery method. Release

> India's Roselabs Bioscience invested $67 million into a pre-filled syringe facility in the country, looking to export its products to 35 countries in Asia, Latin America and Africa. News

> Skyepharma launched its inhaled asthma combination drug in Italy, giving the drug delivery company a $2.6 million milestone payment. The company plans to roll the treatment out in 11 more countries, including France, by the end of 2014. Report

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.